Islamabad: Shifa International Hospitals Ltd. has reported a series of share transactions undertaken by its executives and directors, as part of compliance with disclosure regulations outlined by the Pakistan Stock Exchange (PSX). The company has detailed these transactions, which occurred over several days in late June and early July 2025.

According to the information disclosed, Mohammad Salim Khan, an independent director at Shifa International Hospitals Ltd., executed multiple sell transactions. On June 30, 2025, he sold 2,000 shares at a rate of 463.00 per share. The transaction left him with a cumulative total of 94,451 shares, representing 0.15% of the company's shares. This was followed by another transaction on July 2, 2025, where he sold 2,500 shares at 480.00 per share, reducing his shareholding to 91,951 shares, which also amounted to 0.15%. On July 3, 2025, he further reduced his holdings by selling 1,500 shares at 493.06 per share, resulting in a new total of 90,451 shares, which accounted for 0.14% of the company. A subsequent sale of 510 shares at 518.50 on July 4, 2025, brought his total down to 89,941 shares, maintaining a 0.14% stake.

In a separate transaction, Shaif Shafiq, a member of the senior management, sold 600 shares on July 3, 2025, at a rate of 514.17 per share. Following this sale, Shafiq held 16,750 shares, representing 0.03% of the company’s shares.

Additionally, Malik Gul Muhammad, also part of the senior management, engaged in a buy transaction on July 4, 2025. He acquired 200 shares at a rate of 505.30 per share, marking his first acquisition and holding 200 shares, which did not register as a significant percentage of the company's total shares.

According to information available from the Pakistan Stock Exchange (PSX), these transactions have been conducted following the stipulated regulatory framework for disclosures by directors, executives, and substantial shareholders. The transactions reflect the ongoing adjustments in shareholding by key individuals within the company. The designated market category for these transactions is classified under the CDC Ready market.